Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

Overview of attention for article published in Advances in Therapy, November 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 995 followers.

I'm reading Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies \\http://t.co/3aZ6FNeTYw

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies. http://t.co/ELDK1O3xTM